PROPHASE LABS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01. Regulation FD Disclosure.

On January 13, 2022, ProPhase Labs, Inc. issued a press release providing a business update. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Current Report on Form 8-K, including the exhibit, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit
Number                                 Exhibit Table

99.1        Press Release issued by ProPhase Labs, Inc., dated January 13, 2022.
104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ProPhase Labs, Inc.

                       By: /s/ Monica Brady
                           Monica Brady
                           Chief Financial Officer

Date: January 13, 2022

© Edgar Online, source Glimpses